Metraipolis › archive › dc_fa81ee41e4dc

T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives — Europe PMC PMID:42317371

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42317371
DOI: 10.3389/fimmu.2026.1755512
License (as archived): solo-consultazione
Archived: 2026-10-31T21:41:59.881Z
SHA-256 of the archived text: fd0b8da5c0447901fa17b564d8e3d613eb8dc4c002cd5fcff36aa5079097273d
Stable URL of this page: https://metraipolis.com/documento/dc_fa81ee41e4dc

How to cite

T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives — Europe PMC PMID:42317371 — Europe PMC (en), https://europepmc.org/article/MED/42317371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa81ee41e4dc (Metraipolis archive dc_fa81ee41e4dc, sha256 fd0b8da5c0447901fa17b564d8e3d613eb8dc4c002cd5fcff36aa5079097273d)

BibTeX

@misc{dcfa81ee41e4dc,
  title = {T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives — Europe PMC PMID:42317371},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317371},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa81ee41e4dc; sha256 fd0b8da5c0447901fa17b564d8e3d613eb8dc4c002cd5fcff36aa5079097273d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317371. Agents can read the archived copy with the MCP tool read_document.